Daniel Rosik
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Optical Imaging and Spectroscopy Techniques
-
- HER2/EGFR in Cancer Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 15
- Monoclonal and Polyclonal Antibodies Research 1
-
- Photochromic and Fluorescence Chemistry 1
- Co-authors
- Vladimir Tolmachev (16 shared papers)Anna Orlova (14 shared papers)Mattias Sandström (7 shared papers)Anna Sjöberg (5 shared papers)Anders Wennborg (3 shared papers)Lars Abrahmsén (4 shared papers)Karl Andersson (3 shared papers)Fredrik Y. Nilsson (2 shared papers)
- Journals
- Journal of Nuclear Medicine (4 papers)Bioconjugate Chemistry (4 papers)European Journal of Nuclear Medicine and Molecular Imaging (4 papers)Cancer Research (1 paper)Journal of Molecular Biology (1 paper)
- Partner nations
- SwedenUnited StatesNetherlands
In The Last Decade
Daniel Rosik
16 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 34
- Radiology, Nuclear Medicine and Imaging 959
- Oncology 90
- Biomaterials 41
- Molecular Biology 126
- Immunology 35
Countries citing papers authored by Daniel Rosik
This map shows the geographic impact of Daniel Rosik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rosik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rosik more than expected).
Fields of papers citing papers by Daniel Rosik
This network shows the impact of papers produced by Daniel Rosik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rosik. The network helps show where Daniel Rosik may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rosik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 193 | |
| 2 | 2010 | 140 | |
| 3 | 2009 | 100 | |
| 4 | 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. | 2006 | 97 |
| 5 | 2009 | 94 | |
| 6 | 2007 | 87 | |
| 7 | 2012 | 82 | |
| 8 | 2013 | 82 | |
| 9 | 2011 | 64 | |
| 10 | 2013 | 49 | |
| 11 | 2009 | 46 | |
| 12 | Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors. | 2007 | 33 |
| 13 | 2013 | 29 | |
| 14 | 2020 | 17 | |
| 15 | 2013 | 16 | |
| 16 | 2011 | 13 | |
| 17 | Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA | 2012 | 0 |
About Daniel Rosik
Daniel Rosik is a scholar working on Radiology, Nuclear Medicine and Imaging, Materials Chemistry, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (15 papers), Photochromic and Fluorescence Chemistry (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (959 citations), Oncology (90 citations), Biomaterials (41 citations), Molecular Biology (126 citations) and Immunology (35 citations). Daniel Rosik has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Vladimir Tolmachev, Anna Orlova, Mattias Sandström, Anna Sjöberg, Anders Wennborg, Lars Abrahmsén, Karl Andersson, Fredrik Y. Nilsson, Joakim Galli and Hans Lundqvist. Their work appears in journals such as Journal of Nuclear Medicine, Bioconjugate Chemistry, European Journal of Nuclear Medicine and Molecular Imaging, Cancer Research and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.